Cargando…

Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic systemic inflammatory disease associated with a high prevalence of cardiovascular disease (CVD). Hydroxychloroquine (HCQ) is commonly used to control disease activity in patients with SLE. We evaluated its potential additional therapeutic effect for re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Deng-Ho, Leong, Pui-Ying, Sia, Sung-Kien, Wang, Yu-Hsun, Wei, James Cheng-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616930/ https://www.ncbi.nlm.nih.gov/pubmed/31195632 http://dx.doi.org/10.3390/jcm8060796

Ejemplares similares

Association between endometriosis and risk of systemic lupus erythematosus
por: Fan, Yu-Hsi, et al.
Publicado: (2021)

Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus
por: Fernandes, Mariana Rita de Novaes, et al.
Publicado: (2018)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
por: Piggott, Kisha D, et al.
Publicado: (2018)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
por: Dima, Alina, et al.
Publicado: (2022)

Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine
por: Baalbaki, Sima, et al.
Publicado: (2020)

Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study
por: Lo, Chien-Hsien, et al.
Publicado: (2021)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
por: Piñero, David P., et al.
Publicado: (2017)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
por: Aouhab, Z., et al.
Publicado: (2019)

Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
por: Fasano, Serena, et al.
Publicado: (2023)

Spontaneous Coronary Artery Dissection With Systemic Lupus Erythematosus
por: Chaaban, Nourhan, et al.
Publicado: (2022)

The prevalence and incidence of systemic lupus erythematosus in Taiwan: a nationwide population-based study
por: Leong, Pui-Ying, et al.
Publicado: (2021)

Clinical and Immunologic Profiles in Incomplete Lupus Erythematosus and Improvement with Hydroxychloroquine Treatment
por: Olsen, Nancy J., et al.
Publicado: (2016)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
por: Floris, Alberto, et al.
Publicado: (2018)

Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus
por: Lee, Jae-Eun, et al.
Publicado: (2023)

Successful treatment of massive ascites due to lupus peritonitis with hydroxychloroquine in old- onset lupus erythematosus
por: Hammami, Sonia, et al.
Publicado: (2014)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
por: Fernandez-Ruiz, Ruth, et al.
Publicado: (2020)

Increased risk of being diagnosed with endometriosis in patients with Systemic lupus erythematosus: a population-based cohort study in Taiwan
por: Sun, Yi-Hung, et al.
Publicado: (2022)

Relationship of Hydroxychloroquine and Ophthalmic Complications in Patients with Type 2 Diabetes in Taiwan
por: Chen, Hung-Chih, et al.
Publicado: (2021)

Extensive Discoid Lupus Erythematosus in a HIV patient Responding to Hydroxychloroquine Monotherapy
por: Bhagwat, Pradeep Vittal, et al.
Publicado: (2012)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
por: Bajwa, Asima, et al.
Publicado: (2015)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
por: Wang, Wen-Ming, et al.
Publicado: (2018)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
por: Zahr, Noël, et al.
Publicado: (2021)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
por: Osmani, Zgjim, et al.
Publicado: (2021)

Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
por: Abdelbaky, Mohammed Salah Eldin, et al.
Publicado: (2021)

Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine
por: Reynolds, John A, et al.
Publicado: (2022)

Contrast enhancement imaging in coronary arteries in patients with systemic lupus erythematosus
por: Puntmann, Valentina O, et al.
Publicado: (2012)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
por: O'Laughlin, John P., et al.
Publicado: (2016)

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus
por: Leung, Alexander KC, et al.
Publicado: (2020)

Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose
por: Wakiya, Risa, et al.
Publicado: (2020)

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
por: Cornwell, MacIntosh Grant, et al.
Publicado: (2021)

Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report
por: Wang, Gang, et al.
Publicado: (2021)

Increased Risk of Systemic Lupus Erythematosus in Patients With Helicobacter pylori Infection: A Nationwide Population-Based Cohort Study
por: Wu, Meng-Che, et al.
Publicado: (2020)

Systemic lupus erythematosus in Saudi children: Long-term outcome
por: Al-Mayouf, Sulaiman M
Publicado: (2011)

Long-term cardiac changes in patients with systemic lupus erythematosus
por: de Godoy, Moacir Fernandes, et al.
Publicado: (2013)

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
por: da Silva, Juliana Cruz, et al.
Publicado: (2013)

Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease
por: Salgado Guerrero, Maria, et al.
Publicado: (2020)

Successful hydroxychloroquine treatment in a patient with systemic lupus erythematosus-associated nailfold capillary abnormalities
por: Sugimoto, Tomohiro, et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: can we learn from the use of rituximab in systemic lupus erythematosus?
por: Lekpa, Fernando Kemta, et al.
Publicado: (2021)

Efficacy of Hydroxychloroquine for Improving Pregnancy Outcomes in a Female with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Takaki, Yumika, et al.
Publicado: (2022)

Effect of add-on hydroxychloroquine therapy on serum proinflammatory cytokine levels in patients with systemic lupus erythematosus
por: Wakiya, Risa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8pjp534tpem63h87lssi55r2n5